Bipolar disorder is often characterised by its hallmark manic and depressive episodes. However, a deeper exploration into the lived experiences of those with the condition reveals a spectrum of symptoms that go beyond these well-documented extremes. Among these, one particular symptom stands out for its profound impact on individuals, yet it remains surprisingly under-discussed within both public and professional circles.

HPPD is characterised by a series of symptoms that persist well beyond the initial effects of hallucinogenic substances, such as LSD, MDMA, psilocybin (found in magic mushrooms), and even cannabis. Individuals experiencing HPPD report a range of visual anomalies, including visual snow, trailing images, enhanced colours, and geometric hallucinations, along feelings of depersonalisation and derealisation, plunging them into a relentless state of altered reality.

The condition came to the forefront through the poignant story of Joey, a young man whose life was irrevocably altered after a single encounter with a psychedelic substance. His subsequent struggle with the debilitating effects of HPPD ultimately led to his tragic demise. Joey’s mother, Sheree da Costa, has since been vocal about the need for increased research and understanding of HPPD, advocating for those who suffer in silence.

Despite the profound impact it can have on an individual’s life, HPPD remains under-researched and under-reported. Estimates suggest that around 5% of users of hallucinogenic drugs may experience HPPD, but this figure could be significantly higher due to the stigma surrounding drug use and the lack of awareness about the disorder. Currently, there is no cure for HPPD, with treatment options focusing on managing symptoms rather than addressing the underlying condition.

The medical community is divided over the therapeutic benefits of psychedelics, with some advocating for their use in psychiatric treatment, while others caution against the potential risks, highlighted by disorders like HPPD. This debate has taken on new dimensions with recent moves to deregulate certain psychedelic substances for therapeutic use in Australia, sparking conversations around the safety and long-term effects of these drugs.

The stories of individuals living with HPPD, like Max, who has battled the condition for over a decade, shine a light on the urgent need for greater awareness and understanding. Max’s experience of constant visual disruptions and a feeling of detachment from reality underscores the debilitating nature of HPPD and the importance of informed decision-making when it comes to psychedelic drug use.

As calls for more research into HPPD grow louder, the need for a nuanced approach to the conversation around psychedelic drugs becomes clear. With the rising popularity of these substances for both recreational and therapeutic purposes, understanding their potential to cause lasting harm is crucial.

The narrative surrounding HPPD is not just a cautionary tale about the risks associated with psychedelic drug use; it is also a call to action for the mental health community to shed light on this overlooked condition. For individuals like Joey and Max, and countless others, recognising and addressing the complexities of HPPD is a crucial step towards understanding the full spectrum of mental health challenges in the modern world.

Source: Medium.com

Also see: To Trip or Not to Trip – That is the ‘Killer’ Question?